1. Home
  2. ACP vs EMBC Comparison

ACP vs EMBC Comparison

Compare ACP & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo abrdn Income Credit Strategies Fund

ACP

abrdn Income Credit Strategies Fund

HOLD

Current Price

$5.56

Market Cap

675.0M

Sector

Finance

ML Signal

HOLD

Logo Embecta Corp.

EMBC

Embecta Corp.

HOLD

Current Price

$10.38

Market Cap

755.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACP
EMBC
Founded
2010
1924
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
675.0M
755.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ACP
EMBC
Price
$5.56
$10.38
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$18.50
AVG Volume (30 Days)
337.9K
495.6K
Earning Date
01-01-0001
02-05-2026
Dividend Yield
17.79%
5.59%
EPS Growth
N/A
20.90
EPS
N/A
1.62
Revenue
N/A
$1,080,400,000.00
Revenue This Year
N/A
$2.00
Revenue Next Year
N/A
$0.27
P/E Ratio
N/A
$6.63
Revenue Growth
N/A
N/A
52 Week Low
$5.55
$9.20
52 Week High
$7.17
$19.67

Technical Indicators

Market Signals
Indicator
ACP
EMBC
Relative Strength Index (RSI) 53.41 25.09
Support Level $5.54 $12.01
Resistance Level $5.61 $12.51
Average True Range (ATR) 0.05 0.48
MACD -0.00 -0.21
Stochastic Oscillator 39.13 0.93

Price Performance

Historical Comparison
ACP
EMBC

About ACP abrdn Income Credit Strategies Fund

abrdn Income Credit Strategies Fund is a diversified, closed-end management investment company. Its investment objective is to seek a high level of current income with a secondary objective of capital appreciation. It predominantly invests in debt and loan instruments of issues that operate in a variety of industries and geographic regions.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: